News & Events

Filters

News

Event type

Event region

  • Glasgow 2018—GEMINI-1 and -2 subgroup analyses

    Subgroup analyses by demographic and baseline characteristics in the GEMINI-1 and GEMINI-2 studies. Effectiveness and safety of DTG + 3TC as a 2-drug regimen in HBV-negative, treatment-naïve adults with viral loads up to 500,000 copies/mL.

    Added on: 07/11/2018

  • Glasgow 2018—Viral decay in A5353 pilot study

    Viral decay in A5353, a pilot study of dolutegravir plus lamivudine vs dolutegravir-based triple therapy. 30% of participants had pretreatment viral loads of 100,000 copies/mL to 500,000 copies/mL.

    Added on: 07/11/2018

  • Glasgow 2018—SWORD-1 and -2: Comparison of viral replication

    Comparison of viral replication for DTG + RPV vs 3-drug current antiretroviral regimen in the SWORD-1 and SWORD-2 studies. Week 100 sub-analysis of transient “blips” in the SWORD-1 and SWORD-2 trials.

    Added on: 07/11/2018

  • Glasgow 2018—SWORD-1 and -2: Viral replication below 50 c/mL

    Viral replication below 50 copies/mL DTG + RPV vs 3-drug current antiretroviral regimen. A Week 48 Snapshot analysis of low-level viremia in the SWORD-1 and SWORD-2 studies.

    Added on: 07/11/2018

UK/DTGP/0027/18 - November 2018